Prevalence of prescription errors in the concomitant use of anticonvulsants and hormonal contraceptive drugs, Colombia, 2014

Authors

  • Jorge Enrique Machado-Alba
  • Yeinson Nabor Gallo-Gómez
  • Salomé Hinojosa-Millán

DOI:

https://doi.org/10.18597/rcog.367

Keywords:

Anticonvulsants, contraceptives, pharmacoepidemiology, oral hormonal contraceptives

Abstract

Objective: To determine the prevalence of concomitant prescription of antiepileptic drugs and hormonal contraceptives, and identify wrong prescriptions that may affect the effectiveness of contraception, in a group of women covered under the Colombian General Social Security System in Health (SGSSS).

Materials and methods: Cross-sectional study based on records of women between 15 and 45 years of age who received at least one antiepileptic drug from March 1st to 31st 2014, included in database of a logistic operator for medication distribution for a population belonging to the Contributory and Subsidized regimes in the Colombian social security system. Frequency of concomitant prescription of hormonal contraceptives, type of contraceptives used, and frequency of incorrect prescription of combined use of medications were analysed. Descriptive statistics were used.

Results: Out of a total number of 2092 female users of antiepileptic drugs, there were 89 (4.3%) cases identified with concomitant use of at least one anticonvulsant and one contraceptive. Incorrect prescription of contraceptive methods was identified in 48 cases (54%), including the concomitant use of enzymatic-inducing anticonvulsants and combined hormonal injectable contraceptives (20 cases) or the use of combined low-dose oestrogen oral contraceptives (16 cases) or oral progestins (10 cases) and the use of non enzyme-inducing antiepileptic drugs and combined oral contraceptives, and high-dose oestrogens (2 cases).

Conclusions: An important number of female users of anticonvulsants used hormonal contraception and almost half of them had an incorrect contraceptive prescription, creating a risk of undesired pregnancies or increasing the risk of thromboembolic disease.

Author Biographies

Jorge Enrique Machado-Alba

Médico cirujano; MSc en Farmacoepidemiología; MSc en Farmacología; PhD en Farmacología. Director del Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira. Pereira (Colombia).

Yeinson Nabor Gallo-Gómez

Médico interno, Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira. Pereira (Colombia).

Salomé Hinojosa-Millán

Médico interno, Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira. Pereira (Colombia).

References

Wang H, Bos JH, de Jong-van den Berg LT. Coprescription of antiepileptic drugs and contraceptives. Contraception. 2010;85:28-31.

Vélez A, Eslava-Cobos J. Epilepsy in Colombia: epidemiologic profile and classification of epileptic seizures and syndromes. Epilepsia. 2006;47:193-201.

Dutton C, Foldvary-Schaefery N. Contraception in women with epilepsy: pharmacokinetic interactions, contraceptive options, and management. Int Rev Neurobiol. 2008;83:113-34.

Thorneycroft I, Klein P, Simon J. The impact of antiepileptic drug therapy on steroidal contraceptive efficacy. Epilepsy Behav. 2006;9:31-9.

Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med. 2010;362:2185-93.

McAuley JW, Anderson GD. Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations. Clin Pharmacokinet. 2002;41:559-79.

Haider S, Darney PD. Injectable contraception. Clin Obstet Gynecol. 2007; 50:898-906.

Guillemette T, Yount SM. Contraception and Antiepileptic Drugs. J Midwifery Womens Health. 2012;57:290-5.

Schwenkhagen AM, Stodieck SR. Which contraception for women with epilepsy? Seizure. 2008;17:145-50.

Zupanc ML. Antiepileptic drugs and hormonal contraceptives in adolescent women with epilepsy. Neurology. 2006;28;66:S37-45.

Shorvon SD, Tallis RC, Wallace HK. Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice. J Neurol Neurosurg Psychiatry. 2002;72:114-5.

Morrell MJ, Sarto GE, Shafer PO, Borda EA, Herzog A, Callanan M. Health issues for women with epilepsy: A descriptive survey to assess knowledge and awareness among health care providers. J Womens Health Gend Based Med. 2000;9:959-65.

Krauss GL, Brandt J, Campbell M, Plate C, Summerfield M. Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians. Neurology. 1996;46:1534-9.

Crawford P, Lee P. Gender difference in management of epilepsy–what women are hearing. Seizure. 1999;8:135-9.

How to Cite

1.
Machado-Alba JE, Gallo-Gómez YN, Hinojosa-Millán S. Prevalence of prescription errors in the concomitant use of anticonvulsants and hormonal contraceptive drugs, Colombia, 2014. Rev. colomb. obstet. ginecol. [Internet]. 2016 Mar. 31 [cited 2024 May 11];67(1):13-9. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/367

Downloads

Download data is not yet available.

Published

2016-03-31

Issue

Section

Original Research
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo